You'll be helping save lives
Breast cancer is the most commonly diagnosed cancer amongst women in Australia.
In the last 10 years, breast cancer diagnoses in Australia have increased by around 15%. Every day 56 people in Australia are diagnosed with breast cancer and 9 people still die from the disease every single day. Funding world-class breast cancer research is more important than ever if we want to change the outcomes.
But hope is on the horizon.
The National Breast Cancer Foundation (NBCF) is committed to funding research to reach one determined vision - Zero Deaths from breast cancer.
Who you're helping fund
By taking part in GO PINK and raising funds for NBCF, you're funding world-class breast cancer research focused on better understanding how to prevent and detect breast cancer early, how to stop the progression and recurrence of breast cancer and how to effectively treat hard-to-treat and metastatic breast cancers - research that ultimately saves lives. The more we raise, the more research we can fund.
Here are just a few of the inspiring research projects underway.
ASSOCIATE PROFESSOR TATYANA CHTANOVA
Harnessing the innate immune system to develop new therapies for breast cancer.
Triple Negative Breast Cancer (TNBC) is an aggressive subtype with limited treatment options. Associate Professor Tatyana Chtanova and her team at UNSW Sydney and the Garvan Institute of Medical Research aim to provide a new treatment option for TNBC by developing and optimising a novel immunotherapy that uses bacteria to reprogramme tumour-promoting immune cells to destroy cancer cells.
PROFESSOR NICOLE ‘NIKKI’ VERRILL
New therapeutic approach for treatment-resistant Estrogen Receptor Positive (ER+) breast cancer.
Hormone-blocking (endocrine) therapy is the current standard of care treatment for Estrogen Receptor Positive (ER+) breast cancer. While beneficial for most people, around 30% of people can become resistant to this treatment. Professor Nicole Verrills and her team at the University of Newcastle and Hunter Medical Research Institute (HMRI) will use preclinical models to test a novel treatment to make treatment-resistant ER+ breast cancer more responsive to hormone therapy.
About National Breast Cancer Foundation
NBCF is Australia's leading not-for-profit organisation funding world-class breast cancer research with money raised entirely by the Australian public.
Our vision is simple - Zero Deaths from breast cancer. How? By funding world-class research focused on how to prevent, detect, treat and stop the progression and recurrence of breast cancer.
With your support and generosity, we can achieve our vision and stop deaths from breast cancer.
